Avery Polk

418 total citations
14 papers, 313 citations indexed

About

Avery Polk is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Avery Polk has authored 14 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Avery Polk's work include Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Cell Function and Interaction (4 papers). Avery Polk is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Cell Function and Interaction (4 papers). Avery Polk collaborates with scholars based in United States, Peru and Canada. Avery Polk's co-authors include Ryan A. Wilcox, Nathanael G. Bailey, Megan S. Lim, Ye Lu, Tianjiao Wang, Alexandra C. Hristov, Thomas M. Habermann, Steven C. Ziesmer, Noah A. Brown and Thomas M. Lanigan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Avery Polk

13 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avery Polk United States	7	167	160	139	75	67	14	313
Federica Melle Italy	8	138 0.8×	63 0.4×	131 0.9×	89 1.2×	69 1.0×	18	285
Xiaohong Zhao China	5	134 0.8×	69 0.4×	130 0.9×	233 3.1×	48 0.7×	8	376
Anna Puiggros Spain	9	167 1.0×	131 0.8×	60 0.4×	76 1.0×	48 0.7×	25	345
Dejan Radeski Australia	9	98 0.6×	45 0.3×	140 1.0×	164 2.2×	30 0.4×	20	307
Gandhi Damaj France	8	79 0.5×	177 1.1×	81 0.6×	70 0.9×	16 0.2×	16	288
Clare Gould Australia	7	202 1.2×	288 1.8×	322 2.3×	61 0.8×	10 0.1×	12	457
Ana Batlle Spain	7	151 0.9×	28 0.2×	115 0.8×	51 0.7×	38 0.6×	15	248
Paola Nanni Italy	10	174 1.0×	178 1.1×	96 0.7×	60 0.8×	19 0.3×	13	305
María-Jesús Artiga Spain	7	152 0.9×	52 0.3×	98 0.7×	74 1.0×	16 0.2×	7	243
Kirsty Wienand United States	7	238 1.4×	192 1.2×	233 1.7×	93 1.2×	8 0.1×	15	399

Countries citing papers authored by Avery Polk

Since Specialization

Citations

This map shows the geographic impact of Avery Polk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avery Polk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avery Polk more than expected).

Fields of papers citing papers by Avery Polk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avery Polk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avery Polk. The network helps show where Avery Polk may publish in the future.

Co-authorship network of co-authors of Avery Polk

This figure shows the co-authorship network connecting the top 25 collaborators of Avery Polk. A scholar is included among the top collaborators of Avery Polk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avery Polk. Avery Polk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dumke, Henry, Tycel Phillips, Mark Kaminski, et al.. (2024). Outcomes and prognostic factors of patients diagnosed with relapsed/refractory primary B-cell lymphoma: A retrospective study.. Journal of Clinical Oncology. 42(16_suppl). 7081–7081.

Gao, Xin, Chenguang Wang, Carlos Murga‐Zamalloa, et al.. (2022). Notch Signaling Promotes Mature T-Cell Lymphomagenesis. Cancer Research. 82(20). 3763–3773. 6 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2020). AML-397: Preclinical Efficacy of a PROTAC-based MDM2 Degrader in AML models. Clinical Lymphoma Myeloma & Leukemia. 20. S212–S212. 3 indexed citations

Su, Christopher, Liying Chen, Jason Chen, et al.. (2020). Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM). Blood. 136(Supplement 1). 45–46. 1 indexed citations

Murga‐Zamalloa, Carlos, Delphine Rolland, Avery Polk, et al.. (2019). Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. Clinical Cancer Research. 26(3). 690–703. 48 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2019). Improved Anti-Leukemic Pre-Clinical Efficacy of a Protac Based MDM2 Degrader in a Large AML Cohort. Blood. 134(Supplement_1). 2670–2670. 2 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2019). Superior Pre-Clinical Efficacy of Novel Protac Based BET Degrader in a Large Acute Myeloid Leukemia Cohort. Blood. 134(Supplement_1). 3936–3936. 2 indexed citations

Chen, Liying, Jason Chen, Brian Parkin, et al.. (2019). Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma Patients. Blood. 134(Supplement_1). 4360–4360. 3 indexed citations

Murga‐Zamalloa, Carlos, Avery Polk, Walter Hanel, et al.. (2017). Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas. Oncotarget. 8(70). 114474–114480. 11 indexed citations

10.

Boonstra, Philip S., Avery Polk, Noah A. Brown, et al.. (2017). A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas. American Journal of Hematology. 92(12). 1287–1294. 21 indexed citations

11.

Polk, Avery, Ye Lu, Tianjiao Wang, et al.. (2016). Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(24). 6118–6128. 38 indexed citations

12.

Wang, Tianjiao, Ye Lu, Avery Polk, et al.. (2016). T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. Clinical Cancer Research. 23(10). 2506–2515. 45 indexed citations

13.

Wang, Tianjiao, Andrew L. Feldman, David A. Wada, et al.. (2014). GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 123(19). 3007–3015. 132 indexed citations

14.

Wang, Tianjiao, Avery Polk, Ye Lu, & Ryan A. Wilcox. (2014). T-Cell Receptor Engagement Confers Resistance to Chemotherapy in T-Cell Lymphoproliferative Disorders. Blood. 124(21). 2959–2959. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact